← Browse by Condition
Medical Condition

single ventricle

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 2

ClinicalMetric tracks all active clinical trials for single ventricle sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — single ventricle Clinical Trials

How many clinical trials are currently recruiting for single ventricle?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for single ventricle, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for single ventricle?
single ventricle research spans Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a single ventricle clinical trial?
Eligibility criteria for single ventricle trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Top Sponsors
Stanford University 1 trial
Beijing Anzhen Hospital 1 trial
Driscoll Children's Hospital 1 trial
Leiden University Medical Center 1 trial
Nationwide Children's Hospital 1 trial

Recruiting Clinical Trials

NCT06150950
Recruiting
REHAB Fontan Failure: A Trial of Cardiac Rehabilitation
Enrollment
50 pts
Location
United States
Sponsor
Stanford University
View Trial →
NCT06768008
Recruiting
An Integrated Prenatal and Postnatal Treatment Model for the Treatment of Newborns With Critical Congenital Heart Disease
Enrollment
10,000 pts
Location
China
Sponsor
Beijing Anzhen Hospital
View Trial →
NCT07087782
Recruiting
Impact of Early Fortini Initiation on Growth and Interstage Outcomes in Infants With Single Ventricle Physiology
Enrollment
100 pts
Location
United States
Sponsor
Driscoll Children's Hospital
View Trial →
NCT06932081
Recruiting
Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry
Enrollment
400 pts
Location
United States, Germa...
Sponsor
Leiden University Medical Cent...
View Trial →
NCT04467671 Phase 2
Recruiting
Two-Year Study of the Safety and Efficacy of the Second-Generation Tissue Engineered Vascular Grafts
Enrollment
24 pts
Location
United States
Sponsor
Nationwide Children's Hospital
View Trial →

Related Conditions

congenital heart disease (2) transposition of the great arteries (2) tetralogy of fallot tof (2) heart failure congenital (1) coarctation of aorta (1) aortic stenosis (1) pulmonary atresia (1) pulmonary stenosis (1) truncus arteriosus (1) interrupted aortic arch (1) hypoplastic left heart syndrome hlhs (1) total anomalous pulmonary venous connection (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology